BRCA1 and ovarian cancer: As a result, whether HGSOC constitutes a valid target for ovarian cancer screening remains unanswered and highly contentious with respect to either general-risk or high genetic-risk women, such as germline BRCA1 and BRCA2 mutation carriers, or women with a significant family history of breast or ovarian cancer.